Transgenic mouse models of alzheimer disease: Developing a better model as a tool for therapeutic interventions.

Global prevalence of dementia: a Delphi consensus study

Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659

Alzheimer’s disease

Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles

Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160

A protein factor essential for microtubule assembly

Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089

Amyloid deposition as the central event in the aetiology of Alzheimer’s disease

Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516

A new era for understanding amyloid structures and disease

Iadanza, M. G., Jackson, M. P., Hewitt, E. W., Ranson, N. A., & Radford, S. E. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0060-8 · Cited by 1,002

The case for rejecting the amyloid cascade hypothesis

Herrup, K. (2015) · Nature Neuroscience · doi:10.1038/nn.4017 · Cited by 768

Transcription factor-mediated differentiation of human iPSCs into neurons

Fernandopulle, M. S., Prestil, R., Grunseich, C., Wang, C., Gan, L., & Ward, M. E. (2018) · Current Protocols in Cell Biology · doi:10.1002/cpcb.51 · Cited by 461

Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer’s disease.

Forner, S., Kawauchi, S., Balderrama-Gutierrez, G., Kramár, E. A., Matheos, D. P., Phan, J., Javonillo, D. I., Tran, K. M., Hingco, E., da Cunha, C., et al. (2021) · Scientific Data · doi:10.1038/s41597-021-01054-y · Cited by 501

Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent

Mehdi, S. F., Pusapati, S., Anwar, M. S., Lohana, D., Kumar, P., Nandula, S. A., Nawaz, F. K., Tracey, K., Yang, H., LeRoith, D., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1148209 · Cited by 317

Application of Metabolomics in Alzheimer’s Disease

Wilkins, J. M., & Trushina, E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2017.00719 · Cited by 268

The human connectome in Alzheimer disease — relationship to biomarkers and genetics

Yu, M., Sporns, O., & Saykin, A. J. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00529-1 · Cited by 265

Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop

Zloković, B. V., Gottesman, R. F., Bernstein, K. E., Seshadri, S. S., McKee, A. C., Snyder, H. M., Greenberg, S. M., Yaffe, K. S., Schaffer, C. B., Yuan, C., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12157 · Cited by 252

Harnessing genetic complexity to enhance translatability of Alzheimer’s disease mouse models: A path toward precision medicine

Neuner, S. M., Heuer, S. E., Huentelman, M. J., O’Connell, K. M. S., & Kaczorowski, C. C. (2019) · Neuron · doi:10.1016/j.neuron.2018.11.040 · Cited by 202

Sodium Butyrate Reduces Brain Amyloid-β Levels and Improves Cognitive Memory Performance in an Alzheimer’s Disease Transgenic Mouse Model at an Early Disease Stage

Fernando, W. M. A. D. B., Martins, I. J., Morici, M., Bharadwaj, P., Rainey-Smith, S. R., Lim, W. L. F., & Martins, R. N. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-190120 · Cited by 164

Molecular tweezers for lysine and arginine – powerful inhibitors of pathologic protein aggregation

Schrader, T. H., Bitan, G., & Klärner, F. (2016) · Chemical Communications · doi:10.1039/c6cc04640a · Cited by 138

Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases

Rinauro, D. J., Chiti, F., Vendruscolo, M., & Limbocker, R. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00651-2 · Cited by 138

The neuritic plaque facilitates pathological conversion of tau in an Alzheimer’s disease mouse model

Li, T., Braunstein, K. E., Zhang, J., Lau, A., Sibener, L., Deeble, C., & Wong, P. C. (2016) · Nature Communications · doi:10.1038/ncomms12082 · Cited by 114

Generation of a humanized Aβ expressing mouse demonstrating aspects of Alzheimer’s disease-like pathology

Baglietto‐Vargas, D., Forner, S., Cai, L., Martini, A. C., Trujillo‐Estrada, L., Swarup, V., Nguyen, M. M. T., Huynh, K. D., Javonillo, D. I., Tran, K. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22624-z · Cited by 120

Infection, systemic inflammation, and Alzheimer's disease

Lim, S., Rodríguez‐Ortiz, C. J., & Kitazawa, M. (2015) · Microbes and Infection · doi:10.1016/j.micinf.2015.04.004 · Cited by 117

Perturbations of neural circuitry in aging, mild cognitive impairment, and Alzheimer's disease

Leal, S. L., & Yassa, M. A. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.01.006 · Cited by 114

Modeling and Targeting Alzheimer’s Disease With Organoids

Papaspyropoulos, A., Tsolaki, M., Foroglou, N., & Pantazaki, Α. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00396 · Cited by 107

Neuronal histamine and cognitive symptoms in Alzheimer's disease

Zlomuzica, A., Dere, D., Binder, S., Silva, M. A. D. S., Huston, J. P., & Dere, E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.007 · Cited by 101

Alzheimer’s disease: A clinical perspective and future nonhuman primate research opportunities

Haque, R. U., & Levey, A. I. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912954116 · Cited by 99

Upregulation of miR-181 Decreases c-Fos and SIRT-1 in the Hippocampus of 3xTg-AD Mice

Rodríguez‐Ortiz, C. J., Baglietto‐Vargas, D., Martínez‐Coria, H., LaFerla, F. M., & Kitazawa, M. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140204 · Cited by 99

Small-molecule induction of Aβ-42 peptide production in human cerebral organoids to model Alzheimer's disease associated phenotypes

Pavoni, S., Jarray, R., Nassor, F., Guyot, A.-C., Cottin, S., Rontard, J., Mikol, J., Mabondzo, A., Deslys, J.-P., & Yates, F. (2018) · PLOS ONE · doi:10.1371/journal.pone.0209150 · Cited by 97

Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis

Sakakibara, Y., Sekiya, M., Saito, T., Saido, T. C., & Iijima, K. M. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0446-8 · Cited by 90

Microglial priming and Alzheimer’s disease: a possible role for (early) immune challenges and epigenetics?

Hoeijmakers, L., Heinen, Y., van Dam, A.-M., Lucassen, P. J., & Korosi, A. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00398 · Cited by 85

Increasing cerebral blood flow improves cognition into late stages in Alzheimer’s disease mice

Bracko, O., Njiru, B. N., Swallow, M. A., Ali, M. A., Haft‐Javaherian, M., & Schaffer, C. B. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19873658 · Cited by 89

Aβ plaques

Walker, L. C. (2020) · Free Neuropathology · doi:10.17879/freeneuropathology-2020-3025 · Cited by 113

Induced pluripotent stem cells in Alzheimer’s disease: applications for disease modeling and cell-replacement therapy

Yang, J., Li, S., He, X., Cheng, C., & Le, W. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0106-3 · Cited by 86

Behaviour Hallmarks in Alzheimer’s Disease 5xFAD Mouse Model

Pádua, M. S., Guil‐Guerrero, J. L., & Lopes, P. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126766 · Cited by 87

Brain organoids: a next step for humanized Alzheimer’s disease models?

Gerakis, Y., & Hetz, C. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0343-7 · Cited by 64

Rodent Models of Amyloid-Beta Feature of Alzheimer’s Disease: Development and Potential Treatment Implications

Poon, C. H., Wang, Y., Fung, M., Zhang, C., & Lim, L. W. (2020) · Aging and Disease · doi:10.14336/ad.2019.1026 · Cited by 76

The role of amyloids in Alzheimer's and Parkinson's diseases

Salahuddin, P., Fatima, M. T., Uversky, V. N., Khan, R. H., Islam, Z., & Furkan, M. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.08.197 · Cited by 74

Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer’s disease

Sakakibara, Y., Sekiya, M., Saito, T., Saido, T. C., & Iijima, K. M. (2019) · BMC Neuroscience · doi:10.1186/s12868-019-0496-6 · Cited by 65

Arsenic Exposure Contributes to the Bioenergetic Damage in an Alzheimer’s Disease Model

Niño, S. A., Morales-Martínez, A., Chi-Ahumada, É., Carrizales, L., Salgado‐Delgado, R., Pérez‐Severiano, F., Díaz-Cintra, S. Y., Jiménez-Capdeville, M. E., & Zarazúa, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00278 · Cited by 64

Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview

Bem, A. F. D., Krolow, R., Farias, H. R., de Rezende, V. L., Gelain, D. P., Moreira, J. C. F., Duarte, J. M. N., & de Oliveira, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.604150 · Cited by 69

Transgenic animal models for study of the pathogenesis of Huntington’s disease and therapy

Li, X., Chang, R., Liu, X., & Li, S. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s58470 · Cited by 62

Foundations and implications of astrocyte heterogeneity during brain development and disease

Schober, A. L., Wicki‐Stordeur, L. E., Murai, K. K., & Swayne, L. A. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.06.009 · Cited by 63

Protein aggregation and its affecting mechanisms in neurodegenerative diseases

Wu, J., Wu, J., Chen, T., Cai, J., & Ren, R. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105880 · Cited by 62

Antroquinonol Lowers Brain Amyloid-β Levels and Improves Spatial Learning and Memory in a Transgenic Mouse Model of Alzheimer’s Disease

Chang, W.-H., Chen, M. C., & Cheng, I. H.-J. (2015) · Scientific Reports · doi:10.1038/srep15067 · Cited by 60

Enhanced Neuronal Activity and Asynchronous Calcium Transients Revealed in a 3D Organoid Model of Alzheimer’s Disease

Yin, J., & VanDongen, A. M. J. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01583 · Cited by 63

Early Neuronal Loss and Axonal/Presynaptic Damage is Associated with Accelerated Amyloid-β Accumulation in AβPP/PS1 Alzheimer's Disease Mice Subiculum

Trujillo‐Estrada, L., Dávila, J. C., Sánchez‐Mejías, E., Sanchez-Varo, R. M., Gómez-Arboledas, Á., Vizuete, M., Vitórica, J., & Gutiérrez, A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140495 · Cited by 58

Cerebrovascular phenotypes in mouse models of Alzheimer’s disease

Szu, J. I., & Obenaus, A. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x21992462 · Cited by 49

Neonatal infection leads to increased susceptibility to Aβ oligomer-induced brain inflammation, synapse loss and cognitive impairment in mice

Frost, P. S., Barros‐Aragão, F. G. Q., da Silva, R. T., Venancio, A. M., Matias, I. C. P., Silva, N. M. L. E., Kincheski, G. C., Pimentel‐Coelho, P. M., Felice, F. G. D., Gomes, F. C. A., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1529-x · Cited by 51

Disrupting Self-Assembly and Toxicity of Amyloidogenic Protein Oligomers by “ Molecular Tweezers” - from the Test Tube to Animal Models

Attar, A., & Bitan, G. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990496 · Cited by 48

Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research

Pádua, M. S., Guil-Guerrero, J. L., Prates, J. A. M., & Lopes, P. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052805 · Cited by 46

Age Progression of Neuropathological Markers in the Brain of the Chilean Rodent Octodon degus, a Natural Model of A lzheimer's Disease

Inestrosa, N. C., Ríos, J. A., Cisternas, P., Tapia‐Rojas, C., Rivera, D. S., Braidy, N., Zolezzi, J. M., Godoy, J. A., Carvajal, F. J., Ardiles, Á. O., et al. (2014) · Brain Pathology · doi:10.1111/bpa.12226 · Cited by 47

Neuroprotective effects of exercise in rodent models of memory deficit and Alzheimer's

Jahangiri, Z., Gholamnezhad, Z., & Hosseini, M. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0343-y · Cited by 43

Allograft Inflammatory Factor 1 as an Immunohistochemical Marker for Macrophages in Multiple Tissues and Laboratory Animal Species

Donovan, K. M., Leidinger, M., McQuillen, L. P., Goeken, J. A., Hogan, C. M., Harwani, S. C., Flaherty, H. A., & Meyerholz, D. K. (2018) · Comparative Medicine · doi:10.30802/aalas-cm-18-000017 · Cited by 41

Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase

Catto, M., Berezin, A. A., Re, D. L., Loizou, G., Demetriades, M., Stradis, A. D., Campagna, F., Koutentis, P. A., & Carotti, A. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.10.003 · Cited by 41

Running exercise protects against myelin breakdown in the absence of neurogenesis in the hippocampus of AD mice

Chao, F., Zhang, L., Zhang, Y., Zhou, C., Jiang, L. H., Xiao, Q., Luo, Y., Lv, F., He, Q., & Tang, Y. C. (2018) · Brain Research · doi:10.1016/j.brainres.2018.01.007 · Cited by 43

Development and validation of Alzheimer’s Disease Animal Model for the Purpose of Regenerative Medicine

Goodarzi, P., Payab, M., Alavi-Moghadam, S., Larijani, B. A., Rahim, F., Bana, N., Sarvari, M., Adibi, H., Heravani, N. F., Hadavandkhani, M., et al. (2019) · Cell and Tissue Banking · doi:10.1007/s10561-019-09773-8 · Cited by 38

Assessment of Alzheimer’s Disease Based on Texture Analysis of the Entorhinal Cortex

Leandrou, S., Lamnisos, D., Mamais, I., Kyriacou, P. A., Pattichis, C. S., & Initiative, A. D. N. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00176 · Cited by 38

Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer’s disease

Kong, V., Devenyi, G. A., Gallino, D., Ayranci, G., Germann, J., Rollins, C., & Chakravarty, M. M. (2018) · Brain Structure and Function · doi:10.1007/s00429-018-1691-4 · Cited by 32

mNos2Deletion and HumanNOS2Replacement in Alzheimer Disease Models

Colton, C. A., Wilson, J. G., Everhart, A. L., Wilcock, D. M., Puoliväli, J. T., Heikkinen, T., Oksman, J., Jääskeläinen, O., Lehtimäki, K. K., Laitinen, T., et al. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000094 · Cited by 37

Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications

Essayan-Perez, S., Zhou, B., Nabet, A. M., Wernig, M., & Huang, Y. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104503 · Cited by 40

Cytotoxic species in amyloid-associated diseases: Oligomers or mature fibrils

Siddiqi, M. K., Malik, S., Majid, N., Alam, P., & Khan, R. H. (2019) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2019.06.001 · Cited by 38

Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer’s and Parkinson’s Diseases: Insights into Current Medications

Gautam, D., Naik, U. P., Naik, M. U., Yadav, S. K., Chaurasia, R. N., & Dash, D. (2023) · Biomolecules · doi:10.3390/biom13111609 · Cited by 38

High-Fat Diets in Animal Models of Alzheimer’s Disease: How Can Eating Too Much Fat Increase Alzheimer’s Disease Risk?

Valentin‐Escalera, J., Leclerc, M., & Calon, F. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230118 · Cited by 37

A Novel hAPP/htau Mouse Model of Alzheimer's Disease: Inclusion of APP With Tau Exacerbates Behavioral Deficits and Zinc Administration Heightens Tangle Pathology

Lippi, S. L. P., Smith, M. L., & Flinn, J. M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00382 · Cited by 35

Age and gender differences for the behavioral phenotypes of 3xTg alzheimer's disease mice

Pairojana, T., Phasuk, S., Suresh, P., Huang, S., Pakaprot, N., Chompoopong, S., Hsieh, T., & Liu, I. Y. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147437 · Cited by 42

Inappropriate modeling of chronic and complex disorders: How to reconsider the approach in the context of predictive, preventive and personalized medicine, and translational medicine

Seifirad, S., & Haghpanah, V. (2019) · The EPMA Journal · doi:10.1007/s13167-019-00176-z · Cited by 35

Physiologically-relevant levels of sphingomyelin, but not GM1, induces a β-sheet-rich structure in the amyloid-β(1-42) monomer

Owen, M. C., Kulig, W., Poojari, C., Róg, T., & Strodel, B. (2018) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.03.026 · Cited by 34

Mitigating Effect of Estrogen in Alzheimer’s Disease-Mimicking Cerebral Organoid

Kim, J. Y., Mo, H., Kim, J., Kim, J. W., Nam, Y., Rim, Y. A., & Ju, J. H. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.816174 · Cited by 33

Mitophagy impairment in neurodegenerative diseases: Pathogenesis and therapeutic interventions

Mani, S., Swargiary, G., & Chadha, R. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.01.001 · Cited by 33

Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives

Bhole, R. P., Chikhale, R. V., & Rathi, K. M. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.11.003 · Cited by 34

Status of Metabolomic Measurement for Insights in Alzheimer’s Disease Progression—What Is Missing?

Yin, C., Harms, A. C., Hankemeier, T., Kindt, A. S. D., & de Lange, E. C. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054960 · Cited by 33

An Overview of Astrocyte Responses in Genetically Induced Alzheimer’s Disease Mouse Models

Spanos, F., & Liddelow, S. A. (2020) · Cells · doi:10.3390/cells9112415 · Cited by 32

Syndecan-3 as a Novel Biomarker in Alzheimer’s Disease

Hudák, A., Letoha, A., Vízler, C., & Letoha, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063407 · Cited by 32

Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer’s Disease: Recent Trends and Future Development

Dave, B. P., Shah, Y. B., Maheshwari, K. G., Mansuri, M. K. A., Prajapati, B., Postwala, H. I., & Chorawala, M. R. (2023) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-023-01408-7 · Cited by 33

Mapping Changes in Mouse Brain Metabolism with PET/CT

Welch, A., Mingarelli, M., Riedel, G., & Platt, B. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.121509 · Cited by 31

Emerging Promise of Immunotherapy for Alzheimer’s Disease: A New Hope for the Development of Alzheimer’s Vaccine

Kabir, M. T., Uddin, M. S., Mathew, B., Das, P. K., Perveen, A., & Ashraf, G. M. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200422105156 · Cited by 32

Alzheimer’s Disease-Related Epigenetic Changes: Novel Therapeutic Targets

Paniri, A., Hosseini, M. M., & Akhavan‐Niaki, H. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03626-y · Cited by 34

Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies

Wisely, E. V., Xiang, Y. K., & Oddo, S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu116 · Cited by 28

Spatial reference learning deficits in absence of dysfunctional working memory in the TgF344‐AD rat model of Alzheimer's disease

Tournier, B. B., Barca, C., Fall, A. B., Gloria, Y., Meyer, L., Ceyzériat, K., & Millet, P. (2020) · Genes Brain & Behavior · doi:10.1111/gbb.12712 · Cited by 29

Past to Future: What Animal Models Have Taught Us About Alzheimer’s Disease

Martini, A. C., Forner, S., Trujillo‐Estrada, L., Baglietto‐Vargas, D., & LaFerla, F. M. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179917 · Cited by 27

Amyloid Beta Secreted during Consolidation Prevents Memory Malleability

Finnie, P. S. B., & Nader, K. (2020) · Current Biology · doi:10.1016/j.cub.2020.02.083 · Cited by 30

Exploring Protein Misfolding and Aggregate Pathology in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Interventions

Johnson, J. T., Fila, W. A., & Anumudu, C. K. (2025) · Applied Sciences · doi:10.3390/app151810285 · Cited by 29

Contributions of Mass Spectrometry to the Identification of Low Molecular Weight Molecules Able to Reduce the Toxicity of Amyloid-β Peptide to Cell Cultures and Transgenic Mouse Models of Alzheimer’s Disease

Ştefănescu, R., Stanciu, G. D., Luca, A., Caba, I.-C., Tamba, B.-I., & Mihai, C. T. (2019) · Molecules · doi:10.3390/molecules24061167 · Cited by 25

Amyloid Oligomers, Protofibrils and Fibrils

Siddiqi, M. K., Majid, N., Malik, S., Alam, P., & Khan, R. H. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-28151-9_16 · Cited by 25

Curcugreen Treatment Prevented Splenomegaly and Other Peripheral Organ Abnormalities in 3xTg and 5xFAD Mouse Models of Alzheimer’s Disease

Manna, J., Dunbar, G. L., & Maiti, P. (2021) · Antioxidants · doi:10.3390/antiox10060899 · Cited by 26

βAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer’s Disease

Audrain, M., Souchet, B., Alves, S., Fol, R. R., Viodé, A., Haddjeri-Hopkins, A., Tada, S., Orefice, N. S., Joséphine, C., Bemelmans, A., et al. (2017) · Cerebral Cortex · doi:10.1093/cercor/bhx260 · Cited by 25

Back to the origins: Human brain organoids to investigate neurodegeneration

Faravelli, I., Costamagna, G., Tamanini, S., & Corti, S. (2020) · Brain Research · doi:10.1016/j.brainres.2019.146561 · Cited by 25

Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer’s disease: A narrative review

Maggiore, A., Latina, V., D’Erme, M., Amadoro, G., & Coccurello, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102578 · Cited by 25

Proteomic Profiling of Cerebrum Mitochondria, Myelin Sheath, and Synaptosome Revealed Mitochondrial Damage and Synaptic Impairments in Association with 3 × Tg‐AD Mice Model

Shen, L., Yang, A., Chen, X., Xiao, S., Liu, X., Lin, J., Zhao, Y., Zhang, K., Li, C., Ke, J., et al. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01052-z · Cited by 24

Modeling Alzheimer’s Disease Using Human Brain Organoids

Karmirian, K., Holubiec, M. I., Goto‐Silva, L., Bessone, I. F., Vitória, G., Mello, B., Alloatti, M., Vanderborght, B., Falzone, T. L., & Rehen, S. K. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2655-9_7 · Cited by 25

Spontaneous development of Alzheimer's disease‐associated brain pathology in a Shugoshin‐1 mouse cohesinopathy model

Rao, C. V., Farooqui, M., Zhang, Y., Asch, A. S., & Yamada, H. Y. (2018) · Aging Cell · doi:10.1111/acel.12797 · Cited by 23

Mutant presenilin2 promotes apoptosis through the p53/miR-34a axis in neuronal cells

Li, L., Tu, Q., Deng, X., Xia, J., Hou, D., Guo, K., & Zi, X. (2017) · Brain Research · doi:10.1016/j.brainres.2017.01.034 · Cited by 23

Role of microbes in the pathogenesis of neuropsychiatric disorders

Goswami, A., Wendt, F. R., Pathak, G. A., Tylee, D. S., Angelis, F. D., Lillo, A. D., & Polimanti, R. A. (2021) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2021.100917 · Cited by 21

Aβ1-6A2V(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury

Diomede, L., Zanier, E. R., Moro, F., Vegliante, G., Colombo, L., Russo, L., Cagnotto, A., Natale, C., Xodo, F. M., Luigi, A. D., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02101-3 · Cited by 18

Monitoring Alzheimer’s disease via ultraweak photon emission

Sefati, N., Esmaeilpour, T., Salari, V., Zarifkar, A., Dehghani, F., Ghaffari, M. K., Zadeh‐Haghighi, H., Császár, N., Bókkon, I., Rodrigues, S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108744 · Cited by 20

A Bird’s-Eye View of the Multiple Biochemical Mechanisms that Propel Pathology of Alzheimer’s Disease: Recent Advances and Mechanistic Perspectives on How to Halt the Disease Progression Targeting Multiple Pathways

Vegh, C., Stokes, K., Ma, D., Wear, D., Cohen, J. S., Ray, S. D., & Pandey, S. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181230 · Cited by 19

secHsp70 as a tool to approach amyloid-β42 and other extracellular amyloids

de Mena, L., Chhangani, D., Fernández-Fúnez, P., & Rincón-Limas, D. E. (2017) · Fly · doi:10.1080/19336934.2017.1291104 · Cited by 19

Direct Conversion of Human Fibroblasts to Induced Neurons

Zhou-Yang, L., Eichhorner, S., Karbacher, L., Böhnke, L., Traxler, L., & Mertens, J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1601-7_6 · Cited by 22

The behavioral, pathological and therapeutic features of the triple transgenic Alzheimer's disease (3 × Tg-AD) mouse model strain

Tian, S. L., Ye, T., & Cheng, X. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114505 · Cited by 21

Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets

Ahmadi, S., Khaledi, S., Ahmadi, K., & Hassanzadeh, K. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70688 · Cited by 20

Modelling Alzheimer's disease using human brain organoids: current progress and challenges

Yanakiev, M., Soper, O., Berg, D. A., & Kang, E. (2022) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.40 · Cited by 17

Amyloid oligomers and their membrane toxicity - A perspective study

Nutini, A. (2024) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2024.01.002 · Cited by 17

Applying gene‐editing technology to elucidate the functional consequence of genetic and epigenetic variation in Alzheimer’s disease

Schrauben, M., Dempster, E. L., & Lunnon, K. (2020) · Brain Pathology · doi:10.1111/bpa.12881 · Cited by 17

Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer’s Disease

Jin, L., Pan, Y., Tran, N. L. L., Polychronopoulos, L. N., Warrier, A., Brouwer, K. L. R., & Nicolazzo, J. A. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b01227 · Cited by 17

Coagulansin-A improves spatial memory in 5xFAD Tg mice by targeting Nrf-2/NF-κB and Bcl-2 pathway

Shal, B., Khan, A., Khan, A. U., Ullah, R., Naveed, M., Ali, G., Islam, S. U., Haq, I. U., Mirza, B., & Khan, S. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108860 · Cited by 16

Alzheimer's disease/dementia-associated brain pathology in aging DPP6-KO mice

Lin, L., Petralia, R. S., Holtzclaw, L. A., Wang, Y., Abebe, D. T., & Hoffman, D. A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105887 · Cited by 17

Ergosterol promotes neurite outgrowth, inhibits amyloid-beta synthesis, and extends longevity: In vitro neuroblastoma and in vivo Caenorhabditis elegans evidence

Sillapachaiyaporn, C., Wongwan, C., Mongkolpobsin, K., Nilkhet, S., Isidoro, C., Chuchawankul, S., & Tencomnao, T. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122606 · Cited by 17

Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis

Sanchez-Varo, R. M., Mejias‐Ortega, M., Fernandez-Valenzuela, J. J., Nuñez‐Diaz, C., Cáceres-Palomo, L., Vegas‐Gomez, L., Sánchez‐Mejías, E., Trujillo‐Estrada, L., García‐León, J. A., Moreno‐González, I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105404 · Cited by 136

Mouse Model for Alzheimer’s Disease

Chishti, M. A., & Nakeeb, S. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-285-4_22 · Cited by 2

Overview of Transgenic Mouse Models for Alzheimer's Disease

Myers, A., & McGonigle, P. (2019) · Current Protocols in Neuroscience · doi:10.1002/cpns.81 · Cited by 148

Transgenic mouse models of Alzheimer's disease: phenotype and application.

(2003) · PubMed · doi:10.1097/01.fbp.0000088420.18414.ff · Cited by 147

An Overview of Transgenic Mouse Models for the Study of Alzheimer’s Disease

Lopes, P. A., Pádua, M. S., & Guil‐Guerrero, J. L. (2025) · Journal of dementia and Alzheimer's disease · doi:10.3390/jdad2010002 · Cited by 9